Global Cell Therapy Technologies Markets to 2025 with COVID-19 Impact Analysis
DUBLIN, Feb. 3, 2021 /PRNewswire/ -- The "Cell Therapy Technologies Market Report - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The Global Cell Therapy Technologies Market is Projected to Reach USD 5.6 Billion by 2025 from USD 2.8 Billion in 2020, at a CAGR of 14.4% from 2020 to 2025.
The growth of this market is driven by the rising government investments in cell-based research, increasing incidence of chronic and infectious diseases, a large number of oncology-related cell therapy clinical trials, and increasing GMP certifications for cell therapy production facilities. Also, the emergence of iPSCs as an alternative to ESCs and increased focus on personalized medicine to offer an opportunity for the growth of the market during the forecast period.
Consumables are expected to hold the largest share of the cell therapy technologies market, by product in 2020.
On the basis of product, the market is segmented into consumables, equipment, and systems & software. The consumables segment accounted for the largest share of the cell therapy technologies market in 2019. Factors such as increasing investments by companies to develop advanced products as well as government initiatives for enhancing cell-based research are contributing to the growth of the cell therapy consumables market.
T-cells are expected to hold the largest share of the cell therapy technologies market, in 2020.
On the basis of cell type, the market is segmented into, T-cells, stem cells, and other cells. In 2019, T-cells accounted for the largest share of the cell therapy technologies market. Favorable government initiatives and the increasing demand for T-cell therapies are the key factors driving the growth of this segment.
Cell processing is expected to hold the largest share of the cell therapy technologies market in 2020.
On the basis of process, the market is segmented into cell processing, cell preservation, distribution and handling, and process monitoring and quality control. The cell processing segment dominated the market in 2019. This segment is expected to grow at the highest CAGR during the forecast period. The cell processing stage makes the highest use of cell therapy instruments and media, especially during culture media processing. This is the major factor responsible for the large share and high growth of this segment.
Biopharmaceutical & biotechnology companies and CROs segment commanded the largest share of the cell therapy technologies market in 2020
By end-user, the cell therapy technologies market is segmented into biopharmaceutical & biotechnology companies and CROs and research institutes and cell banks. Biopharmaceutical & biotechnology companies and CROs dominate the market and are expected to grow at the highest CAGR. The large share of this regional segment can primarily be attributed to the high burden of chronic diseases and increasing R&D activities in the pharmaceutical and biotechnology industries.
North America commanded the largest share of the cell therapy technologies market in 2020.
On the basis of region, the cell therapy technologies market is segmented into North America, Europe, Asia Pacific, and Rest of the World. In 2019, North America commanded the largest share of the cell therapy technologies market. The large share of this market segment can be attributed to the increasing incidence of CVD, increasing healthcare expenditure, growing disposable income, growing healthcare awareness, and the availability of technologically advanced devices in the region.
Some of the major players operating in this market are Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany) and Danaher Corporation (US).
Frequently Asked Questions:
- What are the growth opportunities in the cell therapy technologies market across major regions in the future?
- Which type of cells are expected to hold the largest share in the cell therapy technologies market?
- What are the various cell therapy technologies product types and their respective market shares in the overall market?
- Which region has a well-developed cell therapy technologies market?
- What is the impact of COVID-19 on cell therapy technologies market?
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Cell Therapy Technologies Market, by Product
7 Cell Therapy Technologies Market, by Process
8 Cell Therapy Technologies Market, by Cell Type
9 Cell Therapy Technologies Market, by End-user
10 Cell Therapy Technologies Market, by Region
11 Competitive Landscape & Company Profiles
- Avantor, Inc.
- Becton, Dickinson and Company
- Bio-Techne Corporation
- Cellgenix GmbH
- Corning Incorporated
- Danaher Corporation
- Fresenius Medical Care AG & Co. KGaA
- Fujifilm Irvine Scientific
- Hemasoft
- Ixcells Biotechnology
- L7 Informatics
- Lonza Group
- Mak-System
- Maxcyte
- Merck KGaA
- Miltenyi Biotec GmbH
- Organabio, LLC
- Roosterbio
- Sartorius Ag
- Sirion Biotech GmbH
- Stemcell Technologies
- Terumo Bct, Inc.
- Thermo Fisher Scientific
- Werum IT Solutions GmbH
- Wilson Wolf Corporation
For more information about this report visit https://www.researchandmarkets.com/r/f4p4cq
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article